Mortality & Morbidity Margin
Profit from pricing mortality and morbidity risk above actual claims experience — the underwriting profit inside a life policy.
Why you care
When a life insurer sells a term policy, it charges for the risk of you dying or falling ill. If it prices that risk at more than the claims actually turn out to cost, the gap is pure profit. That gap — the mortality and morbidity margin — is the genuine "insurance" profit buried inside a life policy, separate from any investment return.
Run the numbers
An insurer prices a term book expecting ₹8 cr of death claims and collects ₹12 cr of mortality charges. Actual claims come in at ₹8 cr → a ₹4 cr mortality margin (illustrative). This is why pure protection is so profitable — it's almost all margin, with little investment component to share.
Where this goes
The mortality and morbidity margin is one of the core sources of future profit that value of new business is built on. It's also why the product mix matters so much: protection is dense with this margin, while ULIPs carry very little of it.
Why you care
The mortality and morbidity margin is the profit a life insurer makes when the price it charges for death risk (mortality) and illness or disability risk (morbidity) exceeds what those claims actually cost. It is the true underwriting profit inside a life policy — the life-insurance equivalent of a general insurer earning more in premium than it pays in claims.
This is the purest form of insurance profit a life company earns. It is worth isolating because a life insurer really has two profit sources bundled together: the spread it earns investing policyholders' money, and the margin it earns on the risk itself. The mortality and morbidity margin is the second one. When an insurer prices a term policy, it builds in an assumption about how many policyholders will die or claim. If it prices prudently and its underwriting and customer selection are good, actual claims come in below the charge, and the difference is margin. Because protection products (term insurance, health riders) are almost entirely about this risk charge with little investment content, they are dense with mortality margin. That's exactly why they carry the fattest VNB margins. It also means the margin is only as reliable as the underwriting behind it: misprice the risk or select badly, and the margin thins or turns negative.
Run the numbers
A life insurer's term-protection book for a year:
| Amount | |
|---|---|
| Mortality charges collected (priced risk) | ₹12 cr |
| Actual death/health claims incurred | ₹8 cr |
| Mortality & morbidity margin | ₹4 cr |
The insurer charged ₹12 crore for the risk of its policyholders dying or falling ill, and the claims cost ₹8 crore — leaving a ₹4 crore margin on the pure risk (illustrative). Notice there is no investment return in this figure at all; it is profit earned purely from pricing and selecting risk well. This is the "insurance" in life insurance, stripped of the savings and investment wrapper. That's why an insurer that can underwrite protection well, and sell more of it, builds so much more value than one leaning on investment-linked products.
Where this goes
The mortality and morbidity margin is one of the core sources of the future profit stream that value of new business capitalises — the risk profit, as distinct from the investment spread. It is also the reason the life product mix drives value so strongly: protection is thick with mortality margin while ULIPs are thin on it. So an insurer's blend of products largely decides how much of this pure risk profit it earns. Good mortality experience is, in the end, a direct read on how well the life insurer underwrites.